These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 4129196)

  • 1. In vitro immunization to cultured human tumor cells.
    Sharma B; Terasaki PI
    Cancer Res; 1974 Jan; 34(1):115-8. PubMed ID: 4129196
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell-mediated cytotoxicity toward human lymphocytes: comparison between in vivo immunization and in vitro sensitization.
    Mawas C; Christen Y; Legrand L; Dausset J
    Transplant Proc; 1973 Dec; 5(4):1691-5. PubMed ID: 4130078
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor-associated and spontaneous lymphocyte-mediated cytotoxicity against cell lines derived from human urothelium.
    Vilien M
    Dan Med Bull; 1985 Aug; 32(4):199-218. PubMed ID: 3899526
    [No Abstract]   [Full Text] [Related]  

  • 4. Manipulation of immunologically reactive cell populations in vitro. Outline of an approach to specific immunotherapy of cancer.
    Bach ML; Bach FH; Zoschke DC
    Isr J Med Sci; 1973 Mar; 9(3):344-9. PubMed ID: 4145460
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of water-soluble adjuvants on in vitro lymphocyte immunization.
    Sharma B; Koashi O; Mickey MR; Terasaki P
    Cancer Res; 1975 Mar; 35(3):666-9. PubMed ID: 123169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-mediated cytotoxic reactions to tumor associated antigens.
    Herberman RB
    J Reticuloendothel Soc; 1975 Apr; 17(4):236-40. PubMed ID: 50447
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytotoxic action of spleen lymphocytes to simian virus 40-induced tumor cells.
    Egusa K
    Acta Med Okayama; 1973 Aug; 27(3):107-23. PubMed ID: 4357059
    [No Abstract]   [Full Text] [Related]  

  • 8. 51 Chromium-release assay for cell-mediated cytotoxicity of human leukemia and lymphoid tissue-culture cells.
    McCoy JL; Herberman RB; Rosenberg EB; Donnelly FC; Levine PH; Alford C
    Natl Cancer Inst Monogr; 1973 Jun; 37():59-67. PubMed ID: 4123455
    [No Abstract]   [Full Text] [Related]  

  • 9. Formation of cytotoxic lymphocytes in mixed leukocyte culture systems: introduction.
    Cerottini JC; MacDonald HR; Brunner KT
    Transplant Proc; 1973 Dec; 5(4):1621-4. PubMed ID: 4130070
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tumor immunology].
    Cerni CM
    Subsid Med; 1974; 2():21-5. PubMed ID: 4606048
    [No Abstract]   [Full Text] [Related]  

  • 11. Workshop in human tumor immunology.
    Oettgen HF; Bean MA; Klein G
    Cancer Res; 1972 Dec; 32(12):2845-53. PubMed ID: 4345410
    [No Abstract]   [Full Text] [Related]  

  • 12. The genetic basis for cell-mediated lympholysis in mice.
    Sorensen SF; Hawkes SP
    Transplant Proc; 1973 Dec; 5(4):1361-6. PubMed ID: 4272808
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell-mediated lympholysis in vitro with normal lymphocytes as target: specificity and cross-reactivity of the test.
    Miggiano VC; Bernoco D; Lightbody J; Trinchieri G; Ceppellini R
    Transplant Proc; 1972 Jun; 4(2):231-7. PubMed ID: 5034149
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphocyte activation and destruction in vitro in relation to MLC and HL-A.
    Eijsvoogel VP; Du Bois R; Melief CJ; Zeylemaker WP; Raat-Koning L; de Groot-Kooy L
    Transplant Proc; 1973 Mar; 5(1):415-20. PubMed ID: 4121172
    [No Abstract]   [Full Text] [Related]  

  • 15. Specificity of destruction by lymphocytes activated in mixed leukocyte culture.
    Lightbody JJ; Bach FH
    Transplant Proc; 1972 Sep; 4(3):307-10. PubMed ID: 4263510
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of irradiated and mitomycin-treated mouse spleen cells as stimulating cells in mixed lymphocyte cultures and in vitro sensitization.
    Hodes RJ; Terry WD
    J Immunol; 1974 Jul; 113(1):39-44. PubMed ID: 4275549
    [No Abstract]   [Full Text] [Related]  

  • 17. Impaired responsiveness of lymphocytes and serum-inhibitory factors in patients with cancer.
    Suciu-Foca N; Buda J; McManus J; Thiem T; Reemtsma K
    Cancer Res; 1973 Oct; 33(10):2373-7. PubMed ID: 4270240
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the inhibitory effects of lymphocytes from patients with and without cancer on the growth of human tumour cells in culture.
    Jamieson CW
    Br J Surg; 1972 Apr; 59(4):302. PubMed ID: 5020745
    [No Abstract]   [Full Text] [Related]  

  • 19. Alloantiserum-mediated suppression of histocompatibility-linked IR gene controlled immune responses. I. Histocompatibility antigen requirement.
    Bluestein HG
    J Immunol; 1974 Nov; 113(5):1410-6. PubMed ID: 4417776
    [No Abstract]   [Full Text] [Related]  

  • 20. The response of alloimmune human lymphocytes in mixed lymphocyte culture tests.
    Bondevik H; Thorsby E
    Transplant Proc; 1973 Dec; 5(4):1477-80. PubMed ID: 4272813
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.